» Articles » PMID: 35849588

Introducing RiskCommunicator: An R Package to Obtain Interpretable Effect Estimates for Public Health

Overview
Journal PLoS One
Date 2022 Jul 18
PMID 35849588
Authors
Affiliations
Soon will be listed here.
Abstract

Common statistical modeling methods do not necessarily produce the most relevant or interpretable effect estimates to communicate risk. Overreliance on the odds ratio and relative effect measures limit the potential impact of epidemiologic and public health research. We created a straightforward R package, called riskCommunicator, to facilitate the presentation of a variety of effect measures, including risk differences and ratios, number needed to treat, incidence rate differences and ratios, and mean differences. The riskCommunicator package uses g-computation with parametric regression models and bootstrapping for confidence intervals to estimate effect measures in time-fixed data. We demonstrate the utility of the package using data from the Framingham Heart Study to estimate the effect of prevalent diabetes on the 24-year risk of cardiovascular disease or death. The package promotes the communication of public-health relevant effects and is accessible to a broad range of epidemiologists and health researchers with little to no expertise in causal inference methods or advanced coding.

Citing Articles

Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis.

Li Z, Cheng S, Guo B, Ding L, Liang Y, Shen Y Eur Heart J. 2024; 46(7):649-664.

PMID: 38953786 PMC: 11825145. DOI: 10.1093/eurheartj/ehae406.


Exploring the dynamics of COVID-19 in a Greenlandic cohort: Mild acute illness and moderate risk of long COVID.

Moller M, Abelsen T, Sorensen A, Andersson M, Hansen L, Dilling-Hansen C IJID Reg. 2024; 11:100366.

PMID: 38736712 PMC: 11081797. DOI: 10.1016/j.ijregi.2024.100366.


Impact of azithromycin and nitazoxanide on the enteric infections and child growth: Findings from the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) trial.

Guga G, Houpt E, Elwood S, Liu J, Kimathi C, Mosha R PLoS One. 2023; 18(12):e0294110.

PMID: 38127924 PMC: 10734999. DOI: 10.1371/journal.pone.0294110.


Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study.

Spiliopoulos L, Sorensen A, Bager P, Nielsen N, Hansen J, Koch A Am J Epidemiol. 2023; 193(8):1106-1114.

PMID: 37981717 PMC: 11299024. DOI: 10.1093/aje/kwad225.


Lactate-Based Difference as a Determinant of Outcomes following Surgery for Type A Acute Aortic Dissection: A Multi-Centre Study.

Nappi F, Alzamil A, Salsano A, Avtaar Singh S, Gambardella I, Santini F J Clin Med. 2023; 12(19).

PMID: 37834821 PMC: 10573384. DOI: 10.3390/jcm12196177.


References
1.
Schwartz L, Woloshin S, Dvorin E, Welch H . Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks. BMJ. 2006; 333(7581):1248. PMC: 1702463. DOI: 10.1136/bmj.38985.564317.7C. View

2.
Stang A, Poole C, Bender R . Common problems related to the use of number needed to treat. J Clin Epidemiol. 2009; 63(8):820-5. DOI: 10.1016/j.jclinepi.2009.08.006. View

3.
Westreich D, Cole S, Young J, Palella F, Tien P, Kingsley L . The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2012; 31(18):2000-9. PMC: 3641816. DOI: 10.1002/sim.5316. View

4.
Vandenbroucke J, von Elm E, Altman D, Gotzsche P, Mulrow C, Pocock S . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007; 18(6):805-35. DOI: 10.1097/EDE.0b013e3181577511. View

5.
Persoskie A, Ferrer R . A Most Odd Ratio:: Interpreting and Describing Odds Ratios. Am J Prev Med. 2016; 52(2):224-228. PMC: 5253299. DOI: 10.1016/j.amepre.2016.07.030. View